{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:03Z","timestamp":1792182303547,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,6,30]],"date-time":"2005-06-30T00:00:00Z","timestamp":1120089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,6,30]],"date-time":"2005-06-30T00:00:00Z","timestamp":1120089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s10067-005-1093-x","type":"journal-article","created":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T14:47:04Z","timestamp":1120056424000},"page":"507-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Vasculitic complications of interferon-\u03b1 treatment for chronic hepatitis C virus infection: case report and review of the literature"],"prefix":"10.1007","volume":"24","author":[{"given":"Wilke","family":"Beuthien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ullrich","family":"Mellinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes von","family":"Kempis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,30]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette J et al (1999) Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 42:2204\u20132212","journal-title":"Arthritis Rheum"},{"key":"1093_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mus.10118","volume":"25","author":"K Boonyapisit","year":"2002","unstructured":"Boonyapisit K, Katirji B (2002) Severe exacerbation of hepatitis C associated vasculitic neuropathy following treatment with interferon alpha. A case report and literature review. Muscle Nerve 25:909\u2013913","journal-title":"Muscle Nerve"},{"key":"1093_CR3","first-page":"109","volume":"28","author":"P Cacoub","year":"2001","unstructured":"Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L et al (2001) Systemic vasculitis in patients with hepatitis C. J Rheumatol 28:109\u2013118","journal-title":"J Rheumatol"},{"key":"1093_CR4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.1780401113","volume":"40","author":"V Agnello","year":"1997","unstructured":"Agnello V, Abel G (1997) Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 40:2007\u20132015","journal-title":"Arthritis Rheum"},{"key":"1093_CR5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","volume":"106","author":"F Lunel","year":"1994","unstructured":"Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M et al (1994) Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 106:1291\u20131300","journal-title":"Gastroenterology"},{"key":"1093_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-2893.1998.00097.x","volume":"5","author":"C Donada","year":"1998","unstructured":"Donada C, Crucitti A, Danodon V, Tommasi L, Zanette G, Crovatto M et al (1998) Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinemia. J Viral Hep 5:179\u2013185","journal-title":"J Viral Hep"},{"key":"1093_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1874-5326(00)80019-8","volume-title":"Hepatitis C","author":"V Agnello","year":"2000","unstructured":"Agnello V (2000) Mixed cryoglobulinemia and other extrahepatic manifestations of hepatitis C virus infection. In: Liang HJ (ed) Hepatitis C. Academic, San Diego, pp 295\u2013313"},{"key":"1093_CR8","first-page":"889","volume":"19","author":"C Ferri","year":"1992","unstructured":"Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S et al (1992) Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 19:889\u2013895","journal-title":"J Rheumatol"},{"key":"1093_CR9","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/1529-0131(200109)44:9<2118::AID-ART364>3.0.CO;2-X","volume":"44","author":"P Cacoub","year":"2001","unstructured":"Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, Cohen P et al (2001) Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44:2118\u20132124","journal-title":"Arthritis Rheum"},{"key":"1093_CR10","first-page":"2466","volume":"28","author":"M Naarendorp","year":"2001","unstructured":"Naarendorp M, Kallemuchikkal U, Nuovo G, Gorevic P (2001) Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol 28:2466\u20132473","journal-title":"J Rheumatol"},{"key":"1093_CR11","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/art.10699","volume":"46","author":"P Cacoub","year":"2002","unstructured":"Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P et al (2002) Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46:3317\u20133326","journal-title":"Arthritis Rheum"},{"key":"1093_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1056\/NEJM199403173301104","volume":"330","author":"R Misiani","year":"1994","unstructured":"Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi P et al (1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751\u2013756","journal-title":"N Engl J Med"},{"key":"1093_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","volume":"24","author":"G Fattovich","year":"1996","unstructured":"Fattovich G, Giustina G, Favarato S, Ruol A (1996) A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 24:38\u201347","journal-title":"J Hepatol"},{"key":"1093_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","volume":"54","author":"G D\u2019Amico","year":"1998","unstructured":"D\u2019Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54:650\u2013671","journal-title":"Kidney Int"},{"key":"1093_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/sarh.2002.37277","volume":"32","author":"L Wilson","year":"2002","unstructured":"Wilson L, Widman D, Dikman S, Gorevic P (2002) Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 32:163\u2013173","journal-title":"Semin Arthritis Rheum"},{"key":"1093_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jama.274.2.126b","volume":"275","author":"J-R Harle","year":"1995","unstructured":"Harle J-R, Disdier P, Pelletier J, Azulay J-P, Perreard M, Weiller J-P (1995) Dramatic worsening of hepatitis C-related cryoglobulinemia subsequent to treatment with interferon alfa. JAMA 275:126","journal-title":"JAMA"},{"key":"1093_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0140-6736(93)90325-B","volume":"341","author":"R Zimmermann","year":"1993","unstructured":"Zimmermann R, Konig V, Bauditz J, Hopf U (1993) Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinemia, and chronic hepatitis C. Lancet 341:561\u2013562","journal-title":"Lancet"},{"key":"1093_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","volume":"16","author":"D Batisse","year":"2004","unstructured":"Batisse D, Karmochkine M, Jacquot C, Kazatchkine MD, Weiss L (2004) Sustained exacerbation of cryoglobulinemia-related vasculitis following treatment of hepatitis C with peginterferon alfa. Eur J Gastroenterol Hepatol 16:701\u2013703","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1093_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/ard.60.3.290","volume":"60","author":"O Lidove","year":"2001","unstructured":"Lidove O, Cacoub P, Maisonobe T, Thibault V, Piette J-C, L\u00e8ger J-M (2001) Hepatitis C virus with peripheral neuropathy is not always associated with cryoglobulinemia. Ann Rheum Dis 60:290\u2013292","journal-title":"Ann Rheum Dis"},{"key":"1093_CR20","first-page":"175","volume":"42","author":"V Paoletti","year":"2000","unstructured":"Paoletti V, Donnarumma L, De Matteis A, Mammarella A, Labbadia G, Musca A et al (2000) Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection. Panminerva Med 42:175\u2013178","journal-title":"Panminerva Med"},{"key":"1093_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0002-9343(02)01102-6","volume":"112","author":"R Gupta","year":"2002","unstructured":"Gupta R, Singh S, Tang R, Blackwell T, Schiffman J (2002) Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med 112:683\u2013684","journal-title":"Am J Med"},{"key":"1093_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","volume":"42","author":"M Cid","year":"1999","unstructured":"Cid M, Hernandez-Rodriguez J, Robert J, Del Rio A, Casademont J, Coll-Vinent B et al (1999) Interferon-\u03b1 may exacerbate cryoglobulinemia-related ischemic manifestations. Arthritis Rheum 42:1051\u20131055","journal-title":"Arthritis Rheum"},{"key":"1093_CR23","first-page":"403","volume":"23","author":"O Lidove","year":"1999","unstructured":"Lidove O, Cacoub P, Hausfater P, Wechsler B, Frances C, Leger J-M et al (1999) Hepatitis C virus and cryoglobulinemia: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 23:403\u2013406","journal-title":"Gastroenterol Clin Biol"},{"key":"1093_CR24","first-page":"1351","volume":"17","author":"K Negoro","year":"1994","unstructured":"Negoro K, Fukusako T, Morimatsu M (1994) Acute axonal polyneuropathy during interferon a-2a therapy for chronic hepatitis type C. Muscle Nerve 17:1351\u20131352","journal-title":"Muscle Nerve"},{"key":"1093_CR25","first-page":"2488","volume":"24","author":"M Zuber","year":"1997","unstructured":"Zuber M, Gause A (1997) Peripheral neuropathy during interferon-a therapy in patients with cryoglobulinemia and hepatitis virus infection. J Rheumatol 24:2488\u20132489","journal-title":"J Rheumatol"},{"key":"1093_CR26","first-page":"286","volume":"20","author":"J Jefferson","year":"2000","unstructured":"Jefferson J, Johnson R (2000) Treatment of hepatitis C-associated glomerular disease. Semin Nephrol 20:286\u2013292","journal-title":"Semin Nephrol"},{"key":"1093_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","volume":"69","author":"P Gorevic","year":"1980","unstructured":"Gorevic P, Kassab H, Levo Y, Kohn R, Meltzner M, Prose P et al (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287\u2013308","journal-title":"Am J Med"},{"key":"1093_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1067\/mjd.2000.100535","volume":"43","author":"G Gupta","year":"2000","unstructured":"Gupta G, Holmes S, Spence E, Mills P (2000) Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection. J Am Acad Dermatol 43:937\u2013938","journal-title":"J Am Acad Dermatol"},{"key":"1093_CR29","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1023\/A:1026691416498","volume":"44","author":"G Friedmann","year":"1999","unstructured":"Friedmann G, Mehta S, Sherker A (1999) Fatal exacerbation of hepatitis C related cryoglobulinemia with interferon-\u03b1 therapy. Dig Dis Sci 44:1364\u20131365","journal-title":"Dig Dis Sci"},{"key":"1093_CR30","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0041-1345(00)01503-7","volume":"32","author":"Y Kokado","year":"2000","unstructured":"Kokado Y, Takahara S, Ichimaru N, Toki K, Wang J, Permpongkosol S et al (2000) Clinical outcome of HCV infection after renal transplantation. Transplant Proc 32:1940\u20131943","journal-title":"Transplant Proc"},{"key":"1093_CR31","first-page":"79","volume":"14","author":"D Paterton","year":"1996","unstructured":"Paterton D, Fain O, Sehonnou J, Trinchet J, Beugrand M (1996) Severe necrotizing vasculitis in a patient with hepatitis C virus infection treated by interferon. Clin Exp Rheumatol 14:79\u201381","journal-title":"Clin Exp Rheumatol"},{"key":"1093_CR32","first-page":"1656","volume":"24","author":"L La Civita","year":"1997","unstructured":"La Civita L, Pasero G, Ferri C (1997) Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol 24:1656\u20131657","journal-title":"J Rheumatol"},{"key":"1093_CR33","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780390634","volume":"39","author":"C Ferri","year":"1996","unstructured":"Ferri C, La Civita L, Fazzi P, Pasero G (1996) Polymyositis, lung fibrosis and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 39:1074\u20131075","journal-title":"Arthritis Rheum"},{"key":"1093_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0163-4453(98)80022-4","volume":"36","author":"A Gordon","year":"1998","unstructured":"Gordon A, Edgar JD, Finch R (1998) Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J Infect 36:229\u2013230","journal-title":"J Infect"},{"key":"1093_CR35","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1526::AID-MUS23>3.0.CO;2-X","volume":"21","author":"S Scelsa","year":"1998","unstructured":"Scelsa S, Herskovitz S, Reichler B (1998) Treatment of mononeuropathy multiplex in hepatitis C virus and cryoglobulinemia. Muscle Nerve 21:1526\u20131529","journal-title":"Muscle Nerve"},{"key":"1093_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02358379","volume":"29","author":"I Bojic","year":"1994","unstructured":"Bojic I, Lilc D, Radojic C, Mijuskovic P (1994) Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a. J Gastroenterol 29:369\u2013371","journal-title":"J Gastroenterol"},{"key":"1093_CR37","first-page":"1656","volume":"24","author":"R Tambini","year":"1997","unstructured":"Tambini R, Quattrini A, Fracasetti O, Nemni R (1997) Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol 24:1656\u20131657","journal-title":"J Rheumatol"},{"key":"1093_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s004010050740","volume":"94","author":"A Quatrini","year":"1997","unstructured":"Quatrini A, Comi G, Nemni R, Martinelli V, Villa A, Caimi M et al (1997) Axonal neuropathy associated with interferon-a treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol 94:504\u2013508","journal-title":"Acta Neuropathol"},{"key":"1093_CR39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/jnnp.70.3.408","volume":"70","author":"T Irioka","year":"2001","unstructured":"Irioka T, Yamada M, Yamawaki M, Mizusawa H (2001) Acute autonomic and sensory neuropathy after interferon a-2b therapy for chronic hepatitis C. J Neurol Neurosurg Psychiatr 70:408\u2013410","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"1093_CR40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.65.4.604","volume":"65","author":"ME Marzo","year":"1998","unstructured":"Marzo ME, Tintore M, Fabregues O, Montalban O, Codina A (1998) Chronic inflammatory demyelinating neuropathy during treatment with interferon-\u03b1. J Neurol Neurosurg Psychiatr 65:604","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"1093_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<433::AID-MUS17>3.0.CO;2-O","volume":"23","author":"M Merrigiolli","year":"2000","unstructured":"Merrigiolli M, Rowin J (2000) Chronic inflammatory demyelinating neuropathy after treatment with interferon-\u03b1. Muscle Nerve 23:433\u2013435","journal-title":"Muscle Nerve"},{"key":"1093_CR42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archneur.1997.00550190093020","volume":"54","author":"S Rutkove","year":"1997","unstructured":"Rutkove S (1997) An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a. Arch Neurol 54:907\u2013908","journal-title":"Arch Neurol"},{"key":"1093_CR43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0168-8278(05)80331-9","volume":"21","author":"E Manesis","year":"1994","unstructured":"Manesis E, Petrou C, Brouzas D, Hadziyannis S (1994) Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 21:474\u2013477","journal-title":"J Hepatol"},{"key":"1093_CR44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2169\/internalmedicine.33.637","volume":"33","author":"Y Fukumoto","year":"1994","unstructured":"Fukumoto Y, Shigemitsu T, Omura R, Harada T, Okita K (1994) Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C. Intern Med 33:637\u2013640","journal-title":"Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1093-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-005-1093-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1093-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1093-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:07:27Z","timestamp":1659110847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-005-1093-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,30]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-1093-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,30]]},"assertion":[{"value":"13 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}